Skip to main content
  • Bookmarks
  • Register
  • Login

NIH OIR/OTT Logo

Main Menu

  • Partnerships

    Partnerships

    These links provide access to the information that is commonly needed for companies or organizations interested in partnering with NIH. The information here covers the process from researching available technologies through fees associated.

    • Overview
    • Opportunities
    • Featured Technologies
    • Collaboration / CRADAs
    • Licensing Process
    • Forms / Model Agreements
    • Startups
    • Non-Profits
    • License Materials
    • Licensing FAQs
    • Business Opportunities
    • Product Showcase
    • Product Pipeline
    • Federal Register Notices

    The NIH cannot commercialize its discoveries even with its considerable size and resources — it relies instead upon partners. Typically, a royalty-bearing exclusive license agreement with the right to sublicense is given to a company from NIH to use patents, materials, or other assets to bring a therapeutic or vaccine product concept to market.

  • Royalties

    Royalties

    Information for inventors and licensees on the administration of royalties.

    • Information for NIH Inventors
    • Information for Licensees
    • License Notices / Reports
    • Royalty Coordinators
    • NIH Payment Center
    • CDC Payment Center

    Each year, hundreds of new inventions are made at NIH and CDC laboratories. Nine NIH Institutes or Centers (ICs) transfer NIH and CDC inventions through licenses to the private sector for further research and development and eventual commercialization.

  • Reports

    Reports

    These links provide access to reports tracking the success of NIH licensed products.

    • Annual Reports
    • Tech Transfer Statistics
    • Tech Transfer Metrics
    • Commercial Outcomes
    • HHS License-Based Vaccines & Therapeutics
    • Public Health & Economic Impact Study
    • Stories of Discovery
    • Chen Lecture Videos
    • NIH Patents and Active Patent Commercialization Licenses
    • Media Room
    • Tech Transfer Newsletters
    • NIH Patents and Patent Applications

    The NIH, CDC and FDA Intramural Research Programs are exceptionally innovative as exemplified by the many products currently on the market that benefit the public every day. Reports are generated from the commonly tracked metrics related to these products.

  • Resources

    Resources

    These links provide resources to those interested in the technology transfer activities at NIH.

    • Forms and Model Agreements
    • License Notices / Reports
    • Video Library
    • Inventor Resources
    • Presentations & Articles
    • FAQs
    • RSS Feeds
    • Inventor Showcase

    Past videos, lectures, presentations, and articles related to technology transfer at NIH are kept and made available to the public. These topics range from general technology transfer information to processes specific to NIH.

  • Policy & Regulations

    Policies & Regulations

    These links provide access to the policies and regulations surrounding partnering or collaborating with NIH.

    • Freedom of Information Act (FOIA)
    • PHS Technology Transfer Policy
    • Policies & Reports
    • Useful Links

    If a company would like to acquire rights to use or commercialize either an unpatented material, or a patented or patent-pending invention, a license is required. There are numerous policies and regulations surrounding the transfer or a technology from the NIH to a company or organization.

  • About

    About Us

    These links provide information about the Office of Technology Transfer.

    • Contact Us
    • Staff Directory
    • Management
    • FAQs
    • HHS Tech Transfer Offices & Contacts
    • Careers in Tech Transfer
    • Location & Directions
    • Feedback

    The NIH Office of Technology Transfer (OTT) plays a strategic role by supporting the patenting and licensing efforts of our NIH ICs. OTT protects, monitors, markets and manages the wide range of NIH discoveries, inventions, and other intellectual property as mandated by the Federal Technology Transfer Act and related legislation.

Breadcrumb

  1. Home
  2. Taxonomy
  3. Term
  4. NCI

UREIDO DERIVATIVES OF POLY-4-AMINO-2-CARBOXY-1-METHYL PYRROLE COMPOUNDS FOR TREATMENT OF INFLAMMATION

  • Read more about UREIDO DERIVATIVES OF POLY-4-AMINO-2-CARBOXY-1-METHYL PYRROLE COMPOUNDS FOR TREATMENT OF INFLAMMATION
Patent Cooperation Treaty
PCT/US1998/025811
Filed on 1998-12-04

FIBROBLAST GROWTH FACTOR RECEPTOR ACTIVATING GENE I (FRAG1), RELATED PROTEINS AND METHODS

  • Read more about FIBROBLAST GROWTH FACTOR RECEPTOR ACTIVATING GENE I (FRAG1), RELATED PROTEINS AND METHODS
US Patent 6,323,316
Filed on 1998-12-15

Novel Indenoisoquinoline Inhibitors of Topoisomerase I

  • Read more about Novel Indenoisoquinoline Inhibitors of Topoisomerase I
US Application 60/104,226
Filed on 1998-10-14

NEW METHOD OF PREPARATION OF THE CLINICALLY ACTIVE ANTI-HIV AGENT FDDA

  • Read more about NEW METHOD OF PREPARATION OF THE CLINICALLY ACTIVE ANTI-HIV AGENT FDDA
Patent Cooperation Treaty
PCT/US1998/026109
Filed on 1998-12-09

METHOD OF TREATING HIV IN HUMANS BY ADMINISTRATION OF DDI AND HYDROXYC ARBAMIDE

  • Read more about METHOD OF TREATING HIV IN HUMANS BY ADMINISTRATION OF DDI AND HYDROXYC ARBAMIDE
US Patent 5,736,527
Filed on 1996-03-18

MIXTURES OF DDI AND D4T WITH HYDROXYCARBAMIDE FOR INHIBITING RETROVIRA L REPLICATION

  • Read more about MIXTURES OF DDI AND D4T WITH HYDROXYCARBAMIDE FOR INHIBITING RETROVIRA L REPLICATION
US Patent 5,736,526
Filed on 1995-12-22

Mixtures of Dideoxy-Nucleosides and Hydroxycarbamide For Inhibiting Retroviral Spread

  • Read more about Mixtures of Dideoxy-Nucleosides and Hydroxycarbamide For Inhibiting Retroviral Spread
US Patent 6,093,702
Filed on 1995-03-08

MIXTURES OF DIDEOXY-NUCLEOSIDES AND HYDROXYCARBAMIDE FOR INHIBITING RE TROVIRAL SPREAD

  • Read more about MIXTURES OF DIDEOXY-NUCLEOSIDES AND HYDROXYCARBAMIDE FOR INHIBITING RE TROVIRAL SPREAD
US Application 08/378,219
Filed on 1995-01-25

METHOD OF TREATING HIV IN HUMANS BY ADMINISTRATION OF DDI AND HYDROXYC ARBAMIDE

  • Read more about METHOD OF TREATING HIV IN HUMANS BY ADMINISTRATION OF DDI AND HYDROXYC ARBAMIDE
US Patent 5,521,161
Filed on 1993-12-20

ALTERNATIVE OPEN READING FRAME DNA OF A NORMAL GENE AND A NOVEL HUMAN CANCER ANTIGEN ENCODED THEREIN

  • Read more about ALTERNATIVE OPEN READING FRAME DNA OF A NORMAL GENE AND A NOVEL HUMAN CANCER ANTIGEN ENCODED THEREIN
US Patent 6,087,110
Filed on 1998-11-23

Pagination

  • First page « First
  • Previous page ‹‹
  • …
  • Page 1528
  • Page 1529
  • Page 1530
  • Page 1531
  • Page 1532
  • Page 1533
  • Page 1534
  • Page 1535
  • Page 1536
  • …
  • Next page ››
  • Last page Last »
Subscribe to NCI
NIH White Technology Transfer Logo

Return to Top

  • About
  • Privacy Notice
  • Accessibility
  • Web Policies & Notices
  • Open Data
  •  
  • For NIH Staff Only
  • HHS
  • NIH
  • HHS Vulnerability Disclosure
  • Connect
  • Twitter
  • LinkedIn
  • Contact
  • Feedback

Office of Technology Transfer, Office of Intramural Research, National Institutes of Health